Meta-analysis of the efficacy and tolerability of pramipexole and ropinirole in restless legs syndrome (RLS)

被引：0

作者：

Quilici, S.

Nicolas, A.

Abrams, K.

Martin, M.

Lleu, P. L.

Finnern, H.

机构：

[1] i3 Innovus, Uxbridge, Middx, England

[2] Ctr Hosp Vinatier, Bron, France

[3] Univ Leicester, Leicester, Leics, England

[4] Boehringer Ingelheim France, Reims, France

[5] Boehringer Ingelheim GmbH, Ingelheim, Germany

来源：

VALUE IN HEALTH | 2006年 / 9卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)63734-5

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A374 / A374

页数：1

共 50 条

[31] Ropinirole in the Treatment of Restless Legs Syndrome
Vetrugno, Roberto
Montagna, Pasquale
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1237 - 1251
[32] Ropinirole improves objective motor symptoms of Restless Legs Syndrome (RLS) throughout the night
Becker, P. M.
Earl, N. L.
SLEEP, 2006, 29 : A276 - A277
[33] Rapid onset and sustained efficacy of pramipexole in restless Legs syndrome
Ferini-Strambi, Luigi
Aarskog, Dagfinn
Chaudhuri, Ray
Partinen, Markku
Sohr, Mandy
Verri, Daniela
NEUROLOGY, 2008, 70 (11) : A292 - A292
[34] The cost-effectiveness of treating patients with restless legs syndrome (RLS) using ropinirole
Moore, A. P.
Lloyd, A.
Scott, D.
Connolly, M. P.
Dixon, S.
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 116 - 116
[35] Effect of ropinirole treatment on sexual interest and activity in patients with Restless Legs Syndrome (RLS)
Allen, R. P.
Earl, N. L.
SLEEP, 2006, 29 : A276 - A276
[36] The cost-effectiveness of treating patients with restless legs syndrome (RLS) using ropinirole
Moore, AP
Lloyd, A
Scott, DA
Connolly, M
Dixon, S
VALUE IN HEALTH, 2004, 7 (06) : 791 - 791
[37] Long-term tolerability of ropinirole in restless legs syndrome (RLS): Results from two 52-week studies
Lee, D
Earl, NL
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S54 - S54
[38] Efficacy and safety of pramipexole in Japanese patients with restless legs syndrome
Inoue, Y.
Fujita, M.
Shimizu, T.
Emura, N.
Kuroda, K.
Uchimura, N.
MOVEMENT DISORDERS, 2006, 21 : S442 - S442
[39] Ropinirole (Requip) for restless legs syndrome
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1214): : 62 - 64
[40] Tolerability with no loss of efficacy after overnight switch from immediate release (IR) ropinirole to a new extended-release formulation, ropinirole CR, in primary restless legs syndrome (RLS)
Lee, Daniel
Castiglia, Mary
NEUROLOGY, 2007, 68 (12) : A256 - A256

← 1 2 3 4 5 →